A Cohort Based Case Series: Learnings from an Iterative Group Therapy Model to Support Psilocybin-Assisted Therapy for Patients with a Terminal Diagnosis
V. Tsang

TL;DR
This study explores a group therapy model for psilocybin-assisted therapy in terminally ill patients, highlighting benefits and areas for improvement.
Contribution
The paper introduces a novel virtual group therapy model for psilocybin-assisted therapy and evaluates its effectiveness and challenges.
Findings
84% of participants completed the group psilocybin-assisted therapy program.
Themes like improved preparation and relational benefits emerged from participant feedback.
A virtual community of practice was effective for connection and regulation across therapy phases.
Abstract
While much is known about psilocybin-assisted therapy for individuals, little is known about the experience of participants in a group psilocybin therapy model. In an attempt to bridge this gap in the literature, a program development and quality improvement effort was launched. Thirty-one psychedelic-assisted therapy (PaT) sessions were provided for 25 participants within four iterative cohorts over the span of one year. This article reports participant feedback in an effort to inform the benefits and challenges of group-administered PaT. Six to eight once-weekly group resilience-based community of practice (CoP) sessions were combined with one psilocybin-assisted therapy session for patients experiencing distress related to a terminal health condition. The virtual hybrid group therapy model is research informed, with a curriculum that provides knowledge-based content, combined with…
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsPsychedelics and Drug Studies · Chemical synthesis and alkaloids
